Apimeds Pharmaceuticals US
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APUS and other ETFs, options, and stocks.About APUS
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS).
APUS Key Statistics
Stock Snapshot
Apimeds Pharmaceuticals US(APUS) stock is priced at $2.70, giving the company a market capitalization of 4.08M. It carries a P/E multiple of -0.07.
As of 2026-11-07, Apimeds Pharmaceuticals US(APUS) stock has fluctuated between $2.54 and $2.74. The current price stands at $2.70, placing the stock +6.2% above today's low and -1.5% off the high.
The Apimeds Pharmaceuticals US(APUS)'s current trading volume is 16.69K, compared to an average daily volume of 46.92K.
During the past year, Apimeds Pharmaceuticals US(APUS) stock moved between $1.51 at its lowest and $59.70 at its peak.
During the past year, Apimeds Pharmaceuticals US(APUS) stock moved between $1.51 at its lowest and $59.70 at its peak.
APUS News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.